NIVIPI-Brain: Phase 2 Study of Nivolumab plus Ipilimumab Combined With Chemotherapy in NSCLC With Synchronous Brain Metastases
Por:
Nadal E, Cantero A, Paz-Ares L, Ortega A, Barba A, Iranzo P, Domine M, Garcia J, Blasco A, Campelo R, Rodriguez-Abreu D, Castro R, Vidal O, Tena I, Diz P, Provencio M, Simo M, Vilariño N, Navarro , Bruna J
Publicada:
1 oct 2025
Resumen:
|